Vicugna pacos (alpaca): 102541258
Help
Entry
102541258 CDS
T08098
Symbol
CASP3
Name
(RefSeq) caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
vpc
Vicugna pacos (alpaca)
Pathway
vpc01524
Platinum drug resistance
vpc04010
MAPK signaling pathway
vpc04115
p53 signaling pathway
vpc04148
Efferocytosis
vpc04210
Apoptosis
vpc04215
Apoptosis - multiple species
vpc04623
Cytosolic DNA-sensing pathway
vpc04650
Natural killer cell mediated cytotoxicity
vpc04657
IL-17 signaling pathway
vpc04668
TNF signaling pathway
vpc04726
Serotonergic synapse
vpc04932
Non-alcoholic fatty liver disease
vpc04933
AGE-RAGE signaling pathway in diabetic complications
vpc04936
Alcoholic liver disease
vpc05010
Alzheimer disease
vpc05012
Parkinson disease
vpc05014
Amyotrophic lateral sclerosis
vpc05016
Huntington disease
vpc05020
Prion disease
vpc05022
Pathways of neurodegeneration - multiple diseases
vpc05132
Salmonella infection
vpc05133
Pertussis
vpc05134
Legionellosis
vpc05145
Toxoplasmosis
vpc05146
Amoebiasis
vpc05152
Tuberculosis
vpc05160
Hepatitis C
vpc05161
Hepatitis B
vpc05162
Measles
vpc05163
Human cytomegalovirus infection
vpc05164
Influenza A
vpc05165
Human papillomavirus infection
vpc05167
Kaposi sarcoma-associated herpesvirus infection
vpc05168
Herpes simplex virus 1 infection
vpc05169
Epstein-Barr virus infection
vpc05170
Human immunodeficiency virus 1 infection
vpc05200
Pathways in cancer
vpc05203
Viral carcinogenesis
vpc05205
Proteoglycans in cancer
vpc05206
MicroRNAs in cancer
vpc05210
Colorectal cancer
vpc05222
Small cell lung cancer
vpc05416
Viral myocarditis
vpc05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
vpc00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
102541258 (CASP3)
04668 TNF signaling pathway
102541258 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
102541258 (CASP3)
09143 Cell growth and death
04210 Apoptosis
102541258 (CASP3)
04215 Apoptosis - multiple species
102541258 (CASP3)
04115 p53 signaling pathway
102541258 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
102541258 (CASP3)
04650 Natural killer cell mediated cytotoxicity
102541258 (CASP3)
04657 IL-17 signaling pathway
102541258 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
102541258 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
102541258 (CASP3)
05206 MicroRNAs in cancer
102541258 (CASP3)
05205 Proteoglycans in cancer
102541258 (CASP3)
05203 Viral carcinogenesis
102541258 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
102541258 (CASP3)
05222 Small cell lung cancer
102541258 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
102541258 (CASP3)
05161 Hepatitis B
102541258 (CASP3)
05160 Hepatitis C
102541258 (CASP3)
05164 Influenza A
102541258 (CASP3)
05162 Measles
102541258 (CASP3)
05168 Herpes simplex virus 1 infection
102541258 (CASP3)
05163 Human cytomegalovirus infection
102541258 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
102541258 (CASP3)
05169 Epstein-Barr virus infection
102541258 (CASP3)
05165 Human papillomavirus infection
102541258 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
102541258 (CASP3)
05133 Pertussis
102541258 (CASP3)
05134 Legionellosis
102541258 (CASP3)
05152 Tuberculosis
102541258 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
102541258 (CASP3)
05145 Toxoplasmosis
102541258 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
102541258 (CASP3)
05012 Parkinson disease
102541258 (CASP3)
05014 Amyotrophic lateral sclerosis
102541258 (CASP3)
05016 Huntington disease
102541258 (CASP3)
05020 Prion disease
102541258 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
102541258 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
102541258 (CASP3)
05416 Viral myocarditis
102541258 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
102541258 (CASP3)
04932 Non-alcoholic fatty liver disease
102541258 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
102541258 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
102541258 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
vpc01002
]
102541258 (CASP3)
Enzymes [BR:
vpc01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
102541258 (CASP3)
Peptidases and inhibitors [BR:
vpc01002
]
Cysteine peptidases
Family C14: caspase family
102541258 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
SICA_beta
Motif
Other DBs
NCBI-GeneID:
102541258
NCBI-ProteinID:
XP_006198038
UniProt:
A0A6I9HX91
LinkDB
All DBs
Position
26
AA seq
275 aa
AA seq
DB search
MENTENSVDSKSIKTLETNIFHGSKSMDSGLPLDNSYKMDYPEMGLCLIINIKNFHKSTG
MACRSGTDVDAANLRETFTNLKYEVRNKNDLTCEEILKLMYNVSKEDHSKRSSFICVLLS
HGEEGVIYGTDGAVDLKKLTSFFRGDSCRSLTGKPKLFIIQACRGTELDCGIETDSGVED
DMACQKIPIEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLELMHILTRVN
RKVAIEFESFSIDSAFHAKKQIPCIVSMLTKELYF
NT seq
828 nt
NT seq
+upstream
nt +downstream
nt
atggagaacactgaaaactcagtggattcaaaatccattaaaaccttggagacaaatatc
ttccatggaagcaaatcaatggactctggactacccttagacaatagttataaaatggat
tatcctgaaatgggtttatgtttaataattaatattaagaactttcataaaagtactgga
atggcatgtcggtctggtacagatgtagacgcagcaaacctcagggaaacgttcacgaac
ttgaaatacgaagtcagaaataaaaatgatcttacatgtgaagaaattttgaaattaatg
tacaatgtttctaaagaagatcatagcaaaaggagcagtttcatttgtgtgcttctaagc
catggtgaagaaggagtgatttatggaacagatggggctgttgatctgaaaaaattaaca
agcttcttcagaggggacagttgtagaagcctaaccggaaaacccaaacttttcattatt
caggcctgccgaggcacagagctggactgtgggattgagacagacagtggcgttgaggac
gacatggcctgtcagaaaatacccattgaggccgacttcttgtatgcatactccacagca
cctggttactattcctggagaaattcaaaggatggatcctggttcatccagtcactttgt
gcaatgctgaaacagtacgctgacaaacttgagctgatgcacattcttactcgggttaac
cgaaaggtagcaatagagtttgagtctttttccattgactctgcttttcatgcaaagaaa
cagattccatgtattgtgtccatgctcacaaaagaactctatttttaa
DBGET
integrated database retrieval system